ENTITY
idiopathic pulmonary fibrosis
idiopathic pulmonary fibrosis
PulseAugur coverage of idiopathic pulmonary fibrosis — every cluster mentioning idiopathic pulmonary fibrosis across labs, papers, and developer communities, ranked by signal.
Total · 30d
1
2 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
TOPICS
SENTIMENT · 30D
1 day(s) with sentiment data
RECENT · PAGE 1/1 · 2 TOTAL
-
AI accelerates idiopathic pulmonary fibrosis drug discovery timeline
AI played a significant role in the development of Rentosertib, a drug targeting idiopathic pulmonary fibrosis. The AI system identified TNIK as a novel target and optimized the molecular structure, compressing the disc…
-
Insilico Medicine advances AI-discovered drug rentosertib to Phase III trials for IPF
Insilico Medicine is moving its AI-discovered drug, rentosertib, into Phase III clinical trials for idiopathic pulmonary fibrosis (IPF). The drug, which targets the TNIK protein, showed promising results in Phase II tri…